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ABSTRACT
Introduction Greater attention has been directed to
endovascular recanalization of acute ischemic stroke in
septuagenarians and above.
Technique A retrospective chart review was conducted
to include patients treated for acute ischemic stroke from
2006 to 2012. All patients underwent initial neurological
assessment and non-contrast head CT. Patients treated
from 2009 to 2012 additionally received emergent CT
angiogram and CT perfusion. 51 patients met the clinical
and radiographic criteria and underwent multimodal
endovascular revascularization for acute ischemic events.
Results All patients underwent cerebral angiography and
met angiographic criteria for endovascular thrombolysis.
34 patients (67%) were older than 80 years of age. 23
patients (45%) received intravenous tissue plasminogen
activator prior to admission. Eight (16%) patients
underwent stent placement after intra-arterial
thrombolysis, 10 (20%) underwent balloon angioplasty and
seven (14%) underwent both angioplasty and stent
placement. 21 (41%) required only intra-arterial
thrombolytics. An improvement in Thrombolysis in
Myocardial Infarction score was noted in 34 patients
(67%). The average modiﬁed Rankin Scale score on
discharge was 3.9. Symptomatic intracranial hemorrhage
occurred in three patients (6%); none required surgery.
One patient (1.9%) had a postoperative retroperitoneal
hematoma, which was managed conservatively. Two
fatalities resulted from intraoperative vessel rupture
(3.9%), with a combined morbidity and mortality of 27.5%.
Conclusions Multimodal endovascular recanalization of
acute ischemic stroke is a relatively safe treatment option
in patients older than 75 years of age. Careful patient
selection by clinical and radiographic inclusion criteria is
necessary for the successful management of stroke in this
age group.
INTRODUCTION
Stroke is the third leading cause of death in the
USA, and its prevalence is increasing.1–4 Our
demographic ﬁndings include an increase in the
elderly age category of greater than 65 years of age,
with a corresponding increase in the prevalence of
stroke in the elderly.4 With advances in
intra-arterial and mechanical thrombolysis, the
interventional window was ﬁrst extended to 8 h.
Recently, the use of CT perfusion (CTP) has sup-
ported multimodal recanalization beyond 8 h. As a
result, more elderly patients are participating in
endovascular treatment of acute ischemic stroke.5
CTP supports interventions in late diagnosis and
distant referrals from stroke centers lacking in neu-
rointerventional resources.6
Intuitively, minimally invasive treatment would
seem to be better tolerated in the elderly popula-
tion, but data have not supported this hypothesis
to date. Also, endovascular intervention in the
elderly suffering from acute ischemic stroke has
not been thoroughly investigated. Kim et al7 in a
retrospective study comparing 31 elderly patients
undergoing intra-arterial thrombolysis with a
cohort of less than 80 years old, found no signiﬁ-
cant differences in recanalization or intracerebral
hemorrhage, although a lower rate of survival and
excellent outcome was noted in the elderly group.
Similarly, Loh et al8 found a higher likelihood of
death among the elderly cohort after recanaliza-
tion, with similar rates of recanalization and intra-
cranial hemorrhage. Quereshi et al9 in a pooled
analysis of four prospective studies of thrombolysis
in the elderly found in 24 patients a lower likeli-
hood of recanalization and favorable outcome
(modiﬁed Rankin Scale (mRS) score 0–2) along
with increased mortality rates.
Elderly patient populations need to be studied
with regard to interventional stroke care to deter-
mine if traditional therapies can be carried out
without added risk. Angioplasty and stenting are
increasingly performed alongside mechanical and
chemical thrombolysis to maximize recanalization
and improve ﬂow restoration, with favorable
results10–12 Previous studies were limited by their
small sample size. We assessed the safety and efﬁ-
cacy of multimodal endovascular recanalization in
series of 51 patients aged ≥75 years who were
treated in our institution.
METHODS
Institutional review board approval was obtained.
A retrospective chart review was conducted to
include patients over the age of 75 years who were
treated for acute ischemic stroke in our institution
during the period 2009–2012. All patients under-
went initial neurological assessment. Preoperative
evaluation included a non-contrast head CT, which
provided a baseline and excluded patients with
intracranial hemorrhage or completed infarctions.
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In the period between 2006 and 2012, all patients underwent
additional emergent CT angiography and CTP studies. The
decision to proceed with endovascular thrombolysis was deter-
mined based on clinical and radiographic analysis of preopera-
tive data. Inclusion criteria for intervention were a minimum
National Institutes of Health Stroke Scale score of 8, CTP with
ischemic penumbra on mean transient time and cerebral blood
ﬂow but preservation of cerebral blood volume, and detectable
arterial occlusion on CT angiography. All arterial occlusions
were conﬁrmed by subsequent digital subtraction angiography.
CTP has seen increased popularity for rapid assessment of can-
didates for endovascular intervention although its routine use
in clinical practice is still under debate.13–25
Analysis of patient data included inpatient hospital records,
imaging studies, operative reports and outpatient ofﬁce records.
Patient demographics, admission and discharge neurological
examinations, medical comorbidities, such as prior history of
hypertension, diabetes, stroke and smoking, and treatment
complications were recorded and analyzed. Clinical outcome
was evaluated at time of discharge using the mRS.
A total of 51 patients met the clinical and radiographic cri-
teria and underwent multimodal endovascular recanalization
for acute ischemic events. Postoperative course was assessed by
MRI evaluation of stroke territory, incidence of intracranial
hemorrhage and clinical neurological outcome on discharge. All
CT and MRI data were evaluated by staff neuroradiologists.
Thrombolysis in Myocardial Infarction (TIMI) scores were clas-
siﬁed as follows: TIMI 0, no ﬂow beyond the thrombus; TIMI
1, penetrance beyond the thrombus but without perfusion;
TIMI 2, delayed perfusion; TIMI 3, normal perfusion beyond
the thrombus. Time to intervention was deﬁned as time from
symptom onset to groin puncture.
Data acquired were analyzed by the Mann-Whitney U test
and χ2 analysis where appropriate, using a statistical software
package (MedCalc V.12.2.1.0 Mariakerke, Belgium).
Endovascular treatment
Endovascular procedures occurred under general endotracheal
anesthesia. Digital subtraction angiography of the affected
carotid circulation was performed. An 8 French sheath and an
8 French guide catheter were used in most cases. An SL-10
(Stryker, Fremont, California, USA) and Synchro-14 microgui-
dewire (Stryker) were used to cross the occluded arterial
segment and determine the extent of the thrombus. Proximal
internal carotid artery (ICA) occlusions were revascularized
with balloon angioplasty with Viatrac (Abbott, Santa Clara,
California, USA) and Aviator (Cordis, Bridgewater, New Jersey,
USA) balloons. Off-label use of proximal carotid stenting was
achieved with Precise (Cordis), Acculink (Abbott) and Guidant
(Boston Scientiﬁc, Natick, Massachusetts, USA) stents. Once
the cervical carotid circulation was re-established, angiography
was repeated to assess the intracerebral circulation. If a tandem
occlusion was seen in the intracranial circulation, mechanical
thrombolysis was undertaken via a Merci Retriever (Concentric
Medical, Mountainview, California, USA), Penumbra System
(Penumbra Inc, Alameda, California, USA) (n=3), Hyperglide
balloon (EV3, Irvine, California, USA) and Gateway balloon
(Stryker). If mechanical thrombolysis was unsuccessful and
ictus was within 8 h, pharmacologic thrombolysis was per-
formed with intra-arterial tissue plasminogen activator, urokin-
ase or ReoPro. The use of arterial thrombolytics has shifted
throughout the time period reported. Urokinase was predomin-
antly utilized in 2006 but has seen a steady decline in its use in
favor of tissue plasminogen activator. For thrombi that are
resistant to lytics, ReoPro was sometimes used at the discretion
of the interventionalist. Additional intracranial stenting for
tandem middle cerebral artery occlusions was performed with
Wingspan (Stryker) and Enterprise (Cordis) stenting. The off-
label use of the Enterprise stent has gained popularity for
stroke intervention, due to its improved navigability and ease
of deployment in various vessel anatomy (often not navigable
with the Wingspan).26 Finally, in all patients, post thrombolysis
cerebral angiography was repeated to assess the patency of the
extracranial and intracranial carotid circulation.
Postoperative management
Postoperatively, all patients were transferred to the neurointen-
sive care unit for a minimum of 24 h, after which a non-
contrast head CT was routinely performed. All patients who
underwent stent assisted revascularization and had no contra-
indication to antiplatelet therapy received 75 mg of clopidogrel
daily for 6 weeks, as well as 81 mg of aspirin daily, which was
continued indeﬁnitely.
RESULTS
All patients underwent cerebral angiography and met the angio-
graphic criteria for endovascular thrombolysis. There were 35
women and 16 men with a mean age of 81.4 years (range
75–90 years). Thirty-four patients (67%) were >80 years of age.
Thirty-one (60.8%) patients had arterial hypertension, 23
(45.1%) had hypercholesterolemia, 12 (23.5%) had diabetes mel-
litus, 23 (45.1%) had atrial ﬁbrillation and seven (13.7%) were
active smokers. Mean National Institutes of Health Stroke Scale
score was 17.1. The middle cerebral artery was occluded in 39
(76.5%) patients, the ICA in 10 (19.6%) patients and the basilar
artery in two (3.9%) patients. Twenty-three patients (45%)
received intravenous tissue plasminogen activator prior to admis-
sion. Mean time from symptom onset to endovascular inter-
vention was 6.1 h. In 41 patients (80.4%), more than one
endovascular treatment modality was employed (tables 1 and 2).
The penumbra device was used in 23 patients, the Merci device
in nine and both devices in 13. Eight (16%) patients underwent
stent placement, 10 (20%) underwent balloon angioplasty and
seven (14%) underwent both angioplasty and stent placement.
Twenty-one (41%) patients required intra-arterial thromboly-
tics. At baseline, 46 (90.2%) patients had a TIMI score of 0 or 1
(mean TIMI score was 0.19). An improvement in TIMI score
was noted in 34 patients (67%). In 51 patients, post-
recanalization TIMI scores were 0 in 11 (21.5%) patients, 1 in
seven (13.7%) patients, 2 in 14 (27.5%) patients and 3 in 19
(37.3%) patients. A total of 13 (25.4%) patients demonstrated
some degree of intracranial hemorrhage on postoperative
imaging. Nine of 13 hemorrhages were conﬂuent hematomas
(PH-1 and PH-2, by the ECASS (European Cooperative Acute
Stroke Study) classiﬁcation).27 Symptomatic intracranial hem-
orrhage occurred in three patients (6%) but did not require sur-
gical intervention. One patient (1.9%) had a postoperative
retroperitoneal hematoma, which was managed conservatively.
There were two fatalities in our series from intraoperative
vessel rupture (3.9%). The average length of stay was 11.8 days
(1–32). At time of discharge, 33.3% of patients had a favorable
outcome (mRS score 0–3). The average mRS score was 3.9. The
all cause death rate was 21.6% in the series.
DISCUSSION
Acute ischemic stroke is the third leading cause of death in the
USA and the most prevalent neurologic diagnosis. It is also the
most common diagnosis in nursing home residents. With
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advancements in medicine and prolongation of life expectancy,
stroke commonly affects the elderly. Unfortunately, there are
minimal data to support acute endovascular intervention in
this patient population. Additional studies are currently under-
way with the recent publication of the Thrombolysis in Elderly
Stroke Patients in Italy (TESPI), a randomized, controlled trial
evaluating intravenous tissue plasminogen activator versus
standardized medical therapy in patients >80 years of age,
which is currently underway.28
Existing medical comorbidities such as diabetes, hypertension,
cardiac history and renal insufﬁciency increase perioperative
patient risk. Furthermore, vascular anatomical limitations, such
as diffuse atherosclerosis, vessel tortuosity and peripheral vascular
disease, pose additional surgical risks in the elderly. Yet, rapid
reperfusion of the cerebral penumbra remains the gold standard in
acute stroke care. The Carotid Revascularization Endarterectomy
versus Stenting Trial (CREST) supported the notion that ICA
stenting is comparable with carotid endarterecomy in terms of
perioperative morbidity and mortality after 30 day and 2.5 year
follow-ups.28 Later analysis of the CREST data suggested a correl-
ation between increasing age and risk of stroke.28 29
In our series, we investigated the safety and efﬁcacy of multi-
modality endovascular intervention for acute ischemic stroke in
septuagenarians and above. Due to the high surgical risk in this
patient population, careful inclusion criteria were set. The angio-
graphic revascularization rates were good, with a mean TIMI
score of 2 post-recanalization, with 34 patients (67%) achieving
TIMI scores of 2 or greater. Perioperative morbidity was 27.5%,
due to 13 intracranial and one retroperitoneal hemorrhage. Only
three (5.8%) of the 13 intracranial hemorrhages were symptom-
atic. This was less than half the reported rate of symptomatic
intracranial hemorrhage in an analysis of the PROACT II
Table 1 Patient characteristics
Age (years) IV tPA
Lesion location
on angiogram
NIHSS on
admission Endovascular intervention IA lytics TIMI grade
81 N R M1 16 IA lytics Y 2
88 Y R M1 M2 17 IA lytics Y 2
84 N Basilar 10 Stent Y 3
78 Y R M1 19 Balloon angioplasty N 2
85 Y L M1 15 Stent Y 2
90 N R ICA 17 Balloon angioplasty Y 0
87 Y R MCA, R ACA 11 Stent and balloon angioplasty Y 3
77 Y R MCA 22 Stent Y 0
81 Y L ICA, supraclinoid 21 IA lytics N 2
84 N R M1 14 IA lytics Y 3
87 Y L ICA, L PCA 22 Stent N 0
84 N L ICA 13 Stent and balloon angioplasty N 3
88 N L MCA 20 Stent N 0
76 N L M1 26 IA lytics Y 1
79 N R M1 20 IA lytics Y 0
84 Y R M1 17 IA lytics N 2
82 N L ICA stenosis 21 IA lytics N 2
80 Y L ICA, L M1 15 Stent Y 3
78 Y R M1 11 Stent Y 2
82 N R MCA 14 IA lytics N 0
81 N R M1 22 IA lytics Y 2
81 N R M1 11 IA lytics N 3
86 N R ICA, R MCA 10 Stent N 0
87 N L ICA, L MCA 16 IA lytics Y 3
84 N L M1 11 IA lytics N 2
77 Y R M1 14 IA lytics N 3
88 N L MCA 20 IA lytics N 0
76 N L MCA 21 IA lytics Y 2
82 N R M2 14 IA lytics N 0
75 Y L M2 22 Balloon angioplasty N 3
83 Y R MCA 11 IA lytics N 3
85 N R MCA 8 Balloon angioplasty Y 1
77 N L MCA 18 IA lytics Y 3
79 N R MCA 28 Balloon angioplasty Y 2
83 N R ICA 18 IA lytics N 0
75 Y L MCA 12 IA lytics Y 2
82 Y L MCA 16 Stent and balloon angioplasty Y 3
80 Y L MCA 19 Stent and balloon angioplasty N 2
81 Y L MCA 14 Stent and balloon angioplasty N 1
87 Y L M1 27 Stent and balloon angioplasty N 3
78 Y R ICA 9 Balloon angioplasty N 2
83 N R ICA 8 IA lytics N 3
75 Y L MCA 9 Stent and balloon angioplasty Y 3
75 Y R ICA 15 Balloon angioplasty Y 3
ACA, anterior cerebral artery; IA, intra-arterial; ICA, internal carotid artery; IV tPA, intravenous tissue plasminogen activator; L, left; MCA, middle cerebral artery; NIHSS, National Institutes of
Health Stroke Scale; PCA, posterior cerebral artery; R, right; TIMI, Thrombolysis in Myocardial Infarction.
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(Prolyse in Acute Cerebral Thromboembolism II) study.30 In the
aforementioned study, blood glucose >200 mg/dl was associated
with a 36% increased risk of intracranial hemorrhage. The
prevalence of diabetes type I or II was higher in our population
(23.5%), but in our case, this did not increase the rate of hem-
orrhage. The addition of angioplasty and or stent placement
did not appear to have an impact on the overall incidence of
intracranial hemorrhage, despite the need for clopidogrel post-
intervention. Thirty-four per cent of patients underwent stent
placement. While off-label, stent placement has increasingly
been performed in acute stroke, to maximize ﬂow restoration,
with favorable results.10–12 31–33 In the non-operative popula-
tion, hemorrhagic conversion has been reported to range from
15% to as high as 43%.34 Our procedural death rate was 3.9%,
which was due to vessel rupture, as evidenced by contrast
extravasation intraoperatively. In previous series of elderly
patients, time from ictus to endovascular intervention ranged
from a mean of 4.3 to 6.25 h.21 35 Our study had an average
time to intervention of 6.1 h. As a tertiary referral center, most
patients at our center are evaluated at an outside institution
and then transferred on clinical suspicion of stroke. The use of
CTP criteria (which allowed the extension of the therapeutic
window) to select patients for endovascular intervention also
explains the long interval from stroke onset in our study.
Recently, Galimanis et al prospectively followed 623 patients
who underwent endovascular recanalization for stroke. They
concluded that ‘time to treat’ was the only signiﬁcant factor
leading to a better outcome.36 Of one of the largest series to date
involving multimodal recanalization, they found a 5.5% inci-
dence of symptomatic intracranial hemorrhage. Qureshi et al9 in
his study of patients over 80 years old found a rate of 12% intra-
cranial hemorrhage. We found 13 hemorrhages (25.4%) on post-
operative routine imaging. Almost half of these patients had
stent placement. A similarly high rate of hemorrhage was also
reported by Loh et al8 (61%). Difﬁculty arises in comparing rates
of hemorrhage after intervention for a number of reasons. In our
series, the added risk of hemorrhage from stent placement is
unknown. Most importantly, 45% of our elderly cohort received
intravenous tissue plasminogen activator prior to treatment,
compared with 13% in the series by Qureshi and 35% by Loh
et al8 (intra-arterial and intravenous combined). Use of
intra-arterial lytics to date has not used a standardized dose,
which also does not allow for an even comparison across these
three studies. Lastly, Loh et al utilized thrombectomy in all of
their patients, without the use of stent. The observed morbidity
and mortality in our study (21%) compares favorably with
those of Qureshi et al (54%) and Loh et al8 (48%).
The goal of stent placement in the setting of acute ischemic
stroke is recanalization of the occluded vessel. Recanalization
has been shown by Rha et al37 to have a favorable clinical
impact on meta-analysis. A retrospective review of 115 patients
by Al-Ali et al showed that angioplasty had a lower 1 year risk
of recurrent or new stroke than medical management with
warfarin and aspirin. In their study, the risk of stroke was very
similar when comparing bare metal stent to medical manage-
ment (19% vs 18%, respectively).38 Stenting for ﬂow restor-
ation in stroke is feasible with high rates of recanalization.5
Stampﬂ et al showed successful recanalization with stenting in
89% in acute stroke.5 Brekenﬁeld et al followed prospectively 40
consecutive patients with acute ischemic stroke; 43% of
patients underwent Wingspan (Boston Scientiﬁc) stenting and
57% of patients underwent thrombectomy alone with the
Solitaire FR revascularization device (ev3, Plymouth, Minne-
sota, USA). Median ages were comparable (66 and 68 years in
the two groups, respectively). The stented group showed super-
ior rates of recanalization, and earlier time to ﬂow restoration is
seen, which were statistically signiﬁcant.39 Compared with
thrombolysis alone, stent placement demonstrated higher rates
of recanalization as well as comparable morbidity.40
The median age in this group was 81 years. One would
expect a higher morbidity when the results of stroke studies are
translated clinically. Stenting requires a minimum vessel com-
pliance to achieve vessel recanalization safely. In human
studies, Van Lammeren et al41 harvested 1385 carotid plaques
following endarterectomies, ﬁnding a correlation between larger
more calciﬁed plaques among the elderly. They showed that
plaque stability decreased with age. Consequently, the endovas-
cular risk during mechanical thrombolysis in the elderly may
be higher than in the general population. In our patient group,
two patients died as a result of intraoperative rupture following
balloon angioplasty of the distal cervical ICA. Despite the
advanced age in our series, our combined morbidity and mortal-
ity of 27.5% in the practice of multimodal recanalization did
not differ signiﬁcantly from that reported in younger patients.9
Mathews et al42 reviewed 94 consecutive patients who under-
went endovascular therapy after ischemic stroke and found a
combined morbidity and mortality of 26.6%. Again, given the
lack of standardization in new interventional techniques, com-
paring results across studies poses a challenge.
On discharge, 17 patients (33%) had an mRS score of equal
or less than 3, compared with 29% and 16% found by Loh18
and Qureshi20 on discharge, respectively. While the mean age of
the patient population was >80 years, 17 patients were
between the ages of 75 and 80 years. As our series had equiva-
lent to better outcomes than those previously reported, this
potential bias should be noted. In fact, we felt that choosing
an arbitrary cut-off of 75 as opposed to 80 years would provide
a larger patient population for study. The number of patients
older than 80 years (n=34) still comprises 67% of our patient
population and therefore the results should be easily compared
with existing studies.
General anesthesia during acute stroke intervention is stand-
ard practice at our institution at present. Recent literature raises
the concern that general anesthesia may worsen neurologic out-
comes, or even increase morbidity and mortality, compared with
conscious sedation for endovascular recanalization.43 44
However, these observations were reported by retrospective
studies and thus require conﬁrmation by large prospective ran-
domized studies. Our study has some limitation pertaining to
its retrospective design and the absence of a control group
(younger patients). We recognize that given the increased risks
associated with endovascular treatment in this age group and
the strict inclusion criteria for intervention, the patient popula-
tion is rather small. Assessing outcome at discharge may also
Table 2 Baseline characteristics
Total Age <80 years Age >80 years p Value
Male (n (%)) 14 6 8 0.95
Female (n (%)) 37 11 26 0.06
Atrial fibrillation 23 4 19 0.04
Diabetes 12 3 9 0.38
Hypertension 31 23 8 0.04
IV tPA 23 10 13 0.8
NIHSS 17.8 15.7 0.81
Time intervention (h) 6 6.8 0.18
NIHSS, National Institute of Health Stroke Scale; IV tPA, intravenous tissue plasminogen
activator.
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not reﬂect ultimate patient outcome. As mentioned previously,
given the single institutional nature of this study, results are
interpretable mainly to speciﬁc protocols utilized at this institu-
tion. Use of angioplasty and stenting must also be considered
when interpreting results. Larger prospective randomized
studies are required to investigate acute stroke interventions in
this patient population, as little exists in the literature.
CONCLUSION
Multimodal endovascular recanalization of acute ischemic
stroke is a safe treatment option in patients >75 years of age.
Careful patient selection by clinical and radiographic criteria is
necessary for the successful management of stroke in this age
group.
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